Starting on:
Jan 11, 2021
Ending on:
Dec 31, 2021
Moderator(s):
Venue:
Virtual-ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
Jan 11, 2021
Ending on:
Dec 31, 2021
Moderator(s):
Virtual-ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
CRP 102: INTERNATIONAL CANCER INSTITUTE COLORECTAL CANCER PRECEPTORSHIP
Starting on:
Jan 11, 2021 8:00 AM
Jan 11, 2021 8:00 AM
Ending on:
Dec 31, 2021 5:00 PM
Dec 31, 2021 5:00 PM
Venue:
Virtual-ICI
Virtual-ICI
Description
Multidisciplinary management, standards of care, optimal diagnostics, therapies and future perspectives in the care of Colon and Rectal Cancer patients in sub-Saharan Africa incorporating Biosimilars.
Objectives
At the end of this educational activity, participants should be able:
1. To understand the Epidemiology of Colorectal Cancer (Global)
2. To understand colorectal cancer prevention and evidence-based screening guidelines
3. To learn the diagnostics, biological basis, prognostic factors and characterization of colon and rectal cancers, understanding the different biological and pathological subtypes of colon and rectal cancer for the selection of appropriate treatment strategies
4. To understand the role of Surgery in the management of colon and rectal cancer
5. To understand that colon and rectal cancer in early stages are treated differently
6. Evaluate the role of neoadjuvant care, radiotherapy and chemotherapy in rectal cancer
7. To understand the essentials in the assessment and the value of multidisciplinary management of patients with CRC.
8. To understand the role of chemotherapy, monoclonal antibodies and targeted therapy in the management of patients with advanced disease and standard of care protocols.
9. To be knowledgeable about the strengths of, and role of personalized medicine and the importance of offering individualized targeted therapies based on molecular findings such as K-Ras, N-Ras or B-Raf mutations
10. To be knowledgeable on colorectal cancer related hereditary syndromes, the management of families with these and implications for individual patients
11. To understand the role of Palliative, supportive and survivorship care in colorectal cancer management
12. To discuss the role and integration of Biosimilars in Colorectal Cancer management
13. Appreciate the research priority areas in Colorectal cancer in SSA
Presenters
-
Prof.
Chite Asirwa
Consultant Physician, Medical Oncologist & Hematologist
International Cancer Institute -
Dr.
Adem Yesufe
Clinical Oncologist
St. Paul's Hospital, Millennium Medical College in Addis Ababa, Ethiopia -
Dr.
Benjamin Njihia
General Surgeon
St. Francis Hospital, Kasarani -
Dr.
Irene Muramba
Pathologist
Coast General and Provincial Hospital -
Dr.
Irene Weru
Oncology Pharmacist
Kenyatta National Hospital -
Dr.
Esther Nafula
Palliative Care Specialist
Kenyatta National Hospital -
Dr.
Helena Musau
Clinical Oncologist
Kenyatta University Teaching and Referral Hospital -
Dr.
Achille Manirakiza
Clinical Oncologist
King Faisal Hospital, Rwanda -
Prof.
Dinesh Pendharkar
Medical Oncologist, Professor of Medicine
Asian Cancer Institute Mumbai -
Dr.
David Wata
Oncology Pharmacist
Kenyatta National Hospital